A phase II trial of peri-transplant palifermin with busulfan, melphalan and fludarabine followed by T-cell depleted hematopoietic stem cell transplants in patients with advanced myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) evolved from MDS Meeting Abstract
| Authors: | Tamari, R.; Sheetal, S. R.; Kuk, D.; Papadopoulos, E. B.; Jakubowski, A. A.; Boulad, F.; Small, T. N.; Kernan, N. A.; Perales, M. A.; Koehne, G.; Ponce, D. M.; Devlin, S.; Goldberg, J. D.; Young, J. W.; Giralt, S. A.; O'Reilly, R. J.; Castro-Malaspina, H. R. |
| Abstract Title: | A phase II trial of peri-transplant palifermin with busulfan, melphalan and fludarabine followed by T-cell depleted hematopoietic stem cell transplants in patients with advanced myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) evolved from MDS |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000313838903056 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 1935 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
